U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Drug Shortages
  5. Members of the Drug Shortages Task Force
  1. Drug Shortages

Members of the Drug Shortages Task Force

Center for Drug Evaluation and Research

Office of the Center Director
Douglas C. Throckmorton, MD, Deputy Director for Regulatory Programs

Drug Shortages Staff
CAPT Valerie Jensen, R.Ph., Associate Director
CAPT Jouhayna Saliba, Pharm.D., Team Leader
CDR Emily Thakur, R.Ph., Team Leader
CAPT Christine Bina, R.Ph., MPH, Team Leader

Office of Regulatory Policy
Reena Raman, Regulatory Counsel
Michael Bernstein, JD, Director, Division of Regulatory Policy II

Office of Compliance
Ilisa B.G. Bernstein, Pharm.D., JD, Deputy Director, Office of Compliance

CDR Christopher J. Howard, BSN, RN, Consumer Safety Officer/OC Drug Shortage Liaison, Recalls and Shortages Branch

Alternate: Israel Santiago, Branch Chief, Recalls and Shortages Branch

Office of Pharmaceutical Quality
Laurie Graham, Biologist, Office of Policy for Pharmaceutical Quality
Norman Schmuff, Associate Director for Science, Office of Process and Facilities
Jesse Wells, Microbiologist, Office of Process and Facilities
LCDR Leslie A. Rivera Rosado, Ph.D., Director Regulatory Review Officer, Office of Biotechnology Products
Rosa Motta, Associate Director for Program Development, Office of Surveillance
Song (Sonni) Kim, Regulatory Business Process Manager, Office of Program and Regulatory Operations
Hasmukh Patel, Supervisory Chemist, Division of Post-Marketing Activities I
Paul Schwartz, Supervisory Chemist, Division of Post-Marketing Activities II
Patrick Ricucci, Associate Director for Regulatory Affairs, Office of New Drug Products

Office of Strategic Programs
Andreas Schick, Supervisory Economist, OPSA/Economics Staff
Matthew Rosenberg, Operations Research Analyst, OPSA/Economics Staff

Office of Generic Drugs
CDR Kun Shen, Pharm.D., M.S., BCPS, Drug Shortage Coordinator, OGDP
CAPT Martin Shimer, Deputy Division Director, DLRS/OGDP
Tawni Schwemer, Project Manager, Immediate Office, OGDP

Office of Executive Programs
Ryan Hoshi, Ph.D., Regulatory Health Project Manager
Patrick Cannon, JD, Project Manager

Center for Biologics Evaluation and Research

Office of the Center Director
Diane Maloney, JD, Associate Director for Policy

Office of Compliance and Biologics Quality
Joseph P. Manik, Special Assistant for Imports and Product Availability
Anita Richardson, Associate Director for Policy

Office of Regulatory Affairs

Office of Medical Products and Tobacco Operations
Susanne Richardson, Consumer Safety Officer (Drug Program Expert)

Back to Top